Atlas Trials

Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP1601, and the Effect of Food on ZSP1601 Pharmacokinetics

Clinical trial NCT03392779 · COMPLETED

Trial details

NCT number
NCT03392779
Sponsor
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Nonalcoholic Steatohepatitis (NASH)
Start date
2018-01-05
Primary completion
2018-12-21
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.